Annual Shareholders Equity
$39.51 M
-$33.18 M-45.64%
30 April 2024
Summary:
PharmaCyte Biotech annual stockholders equity is currently $39.51 million, with the most recent change of -$33.18 million (-45.64%) on 30 April 2024. During the last 3 years, it has risen by +$32.84 million (+491.58%). PMCB annual shareholders equity is now -56.06% below its all-time high of $89.92 million, reached on 30 April 2022.PMCB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$53.04 M
+$13.53 M+34.23%
31 July 2024
Summary:
PharmaCyte Biotech quarterly stockholders equity is currently $53.04 million, with the most recent change of +$13.53 million (+34.23%) on 31 July 2024. Over the past year, it has dropped by -$5.02 million (-8.65%). PMCB quarterly shareholders equity is now -42.42% below its all-time high of $92.12 million, reached on 31 October 2021.PMCB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.6% | -8.7% |
| 3 y3 years | +491.6% | -42.4% |
| 5 y5 years | +684.1% | +1069.7% |
PMCB Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -56.1% | +491.6% | -42.4% | +34.2% |
| 5 y | 5 years | -56.1% | +684.1% | -42.4% | +1128.0% |
| alltime | all time | -56.1% | +1547.8% | -42.4% | +2043.4% |
PharmaCyte Biotech Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | $53.04 M(+34.2%) |
| Apr 2024 | $39.51 M(-45.6%) | $39.51 M(-19.2%) |
| Jan 2024 | - | $48.89 M(-15.8%) |
| Oct 2023 | - | $58.07 M(-2.4%) |
| July 2023 | - | $59.48 M(-18.2%) |
| Apr 2023 | $72.69 M(-19.2%) | $72.69 M(-5.7%) |
| Jan 2023 | - | $77.12 M(-4.8%) |
| Oct 2022 | - | $81.04 M(-6.1%) |
| July 2022 | - | $86.30 M(-4.0%) |
| Apr 2022 | $89.92 M(+1246.2%) | $89.92 M(-1.5%) |
| Jan 2022 | - | $91.33 M(-0.9%) |
| Oct 2021 | - | $92.12 M(+1512.7%) |
| July 2021 | - | $5.71 M(-14.5%) |
| Apr 2021 | $6.68 M(+31.3%) | $6.68 M(-12.3%) |
| Jan 2021 | - | $7.61 M(-8.0%) |
| Oct 2020 | - | $8.28 M(+32.5%) |
| July 2020 | - | $6.25 M(+22.7%) |
| Apr 2020 | $5.09 M(+1.0%) | $5.09 M(+17.8%) |
| Jan 2020 | - | $4.32 M(-4.7%) |
| Oct 2019 | - | $4.53 M(-9.3%) |
| July 2019 | - | $5.00 M(-0.8%) |
| Apr 2019 | $5.04 M(-12.6%) | $5.04 M(-6.1%) |
| Jan 2019 | - | $5.37 M(-0.7%) |
| Oct 2018 | - | $5.40 M(-12.8%) |
| July 2018 | - | $6.20 M(+7.4%) |
| Apr 2018 | $5.77 M(-28.7%) | $5.77 M(-1.2%) |
| Jan 2018 | - | $5.84 M(-20.6%) |
| Oct 2017 | - | $7.35 M(-15.1%) |
| July 2017 | - | $8.66 M(+7.1%) |
| Apr 2017 | $8.09 M(+24.0%) | $8.09 M(+14.9%) |
| Jan 2017 | - | $7.04 M(+12.0%) |
| Oct 2016 | - | $6.28 M(-11.1%) |
| July 2016 | - | $7.07 M(+8.3%) |
| Apr 2016 | $6.52 M(-16.1%) | $6.52 M(-6.0%) |
| Jan 2016 | - | $6.94 M(+5.7%) |
| Oct 2015 | - | $6.56 M(-5.7%) |
| July 2015 | - | $6.96 M(-10.6%) |
| Apr 2015 | $7.78 M(-13.0%) | $7.78 M(+24.5%) |
| Jan 2015 | - | $6.25 M(-2.1%) |
| Oct 2014 | - | $6.38 M(-18.5%) |
| July 2014 | - | $7.83 M(-12.5%) |
| Apr 2014 | $8.94 M | $8.94 M(+72.5%) |
| Jan 2014 | - | $5.18 M(+43.8%) |
| Oct 2013 | - | $3.60 M(+50.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| July 2013 | - | $2.40 M(-360.4%) |
| Apr 2013 | -$921.50 K(-45.8%) | -$921.50 K(-36.4%) |
| Jan 2013 | - | -$1.45 M(-29.5%) |
| Oct 2012 | - | -$2.05 M(-13.4%) |
| July 2012 | - | -$2.37 M(+39.6%) |
| Apr 2012 | -$1.70 M(-37.7%) | -$1.70 M(-24.4%) |
| Jan 2012 | - | -$2.25 M(-5.4%) |
| Oct 2011 | - | -$2.38 M(-1.3%) |
| July 2011 | - | -$2.41 M(-11.8%) |
| Apr 2011 | -$2.73 M(+11.4%) | -$2.73 M(+23.0%) |
| Jan 2011 | - | -$2.22 M(+4.1%) |
| Oct 2010 | - | -$2.13 M(+2.2%) |
| July 2010 | - | -$2.09 M(-14.9%) |
| Apr 2010 | -$2.45 M(-178.5%) | -$2.45 M(-269.4%) |
| Jan 2010 | - | $1.45 M(-51.6%) |
| Oct 2009 | - | $2.99 M(-6.2%) |
| July 2009 | - | $3.19 M(+2.0%) |
| Apr 2009 | $3.12 M(-58.0%) | $3.12 M(-43.7%) |
| Jan 2009 | - | $5.55 M(-11.7%) |
| Oct 2008 | - | $6.29 M(-9.5%) |
| July 2008 | - | $6.95 M(-6.5%) |
| Apr 2008 | $7.44 M(+73.5%) | $7.44 M(+75.4%) |
| Jan 2008 | - | $4.24 M(+37.4%) |
| Oct 2007 | - | $3.09 M(-21.0%) |
| July 2007 | - | $3.91 M(-8.9%) |
| Apr 2007 | $4.29 M(-2.8%) | $4.29 M(+31.4%) |
| Jan 2007 | - | $3.26 M(-7.8%) |
| Oct 2006 | - | $3.54 M(-7.3%) |
| July 2006 | - | $3.82 M(-13.4%) |
| Apr 2006 | $4.41 M(-440.7%) | $4.41 M(-476.4%) |
| Jan 2006 | - | -$1.17 M(-28.2%) |
| Oct 2005 | - | -$1.63 M(+1.6%) |
| July 2005 | - | -$1.61 M(+24.0%) |
| Apr 2005 | -$1.30 M(+744.3%) | -$1.30 M(-40.1%) |
| Jan 2005 | - | -$2.16 M(+25.9%) |
| Oct 2004 | - | -$1.72 M(+234.4%) |
| July 2004 | - | -$513.10 K(+234.5%) |
| Apr 2004 | -$153.40 K(+6036.0%) | -$153.40 K(-125.2%) |
| Jan 2004 | - | $608.60 K(-5.6%) |
| Oct 2003 | - | $644.40 K(<-9900.0%) |
| July 2003 | - | -$4300.00(+72.0%) |
| Apr 2003 | -$2500.00(-68.4%) | -$2500.00(-71.9%) |
| Jan 2003 | - | -$8900.00 |
| Apr 2002 | -$7900.00 | - |
FAQ
- What is PharmaCyte Biotech annual stockholders equity?
- What is the all time high annual shareholders equity for PharmaCyte Biotech?
- What is PharmaCyte Biotech annual shareholders equity year-on-year change?
- What is PharmaCyte Biotech quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for PharmaCyte Biotech?
- What is PharmaCyte Biotech quarterly shareholders equity year-on-year change?
What is PharmaCyte Biotech annual stockholders equity?
The current annual shareholders equity of PMCB is $39.51 M
What is the all time high annual shareholders equity for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual stockholders equity is $89.92 M
What is PharmaCyte Biotech annual shareholders equity year-on-year change?
Over the past year, PMCB annual stockholders equity has changed by -$33.18 M (-45.64%)
What is PharmaCyte Biotech quarterly stockholders equity?
The current quarterly shareholders equity of PMCB is $53.04 M
What is the all time high quarterly shareholders equity for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly stockholders equity is $92.12 M
What is PharmaCyte Biotech quarterly shareholders equity year-on-year change?
Over the past year, PMCB quarterly stockholders equity has changed by -$5.02 M (-8.65%)